Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Constipation

Therapeutic area intelligence for Constipation with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Companies

StrategyAugust 1, 2026

The FDA has granted approval for Alembic's Abbreviated New Drug Application for Prucalopride Succinate.

RegulatoryJuly 8, 2026

The FDA has granted approval for Prucalopride Succinate under application ANDA219180 submitted by Micro Labs.

No catalysts indexed for this entity yet.

No related entities indexed yet.

Newsletter

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.